Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Quetzal Therapeutics
QTX-2101 Awarded FDA Fast Track Designation for the Treatment of Acute Promyelocytic Leukemia
January 29, 2026
From
Quetzal Therapeutics
Via
GlobeNewswire
Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)
December 02, 2025
From
Quetzal Therapeutics
Via
GlobeNewswire
Quetzal Therapeutics Appoints Todd Smith as Board Member
November 12, 2025
From
Quetzal Therapeutics
Via
GlobeNewswire
Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
September 16, 2025
From
Quetzal Therapeutics
Via
GlobeNewswire
Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital
July 16, 2025
From
Quetzal Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.